Triple-negative breast cancer (TNBC), a subtype that does not overexpress estrogen receptor, progesterone receptor or human epidermal growth factor receptor 2 (HER2) gene (ER−/PR−/HER2−), is a minimally methylated cancer. This evidence concerns the gene ERBB2 and cancer.